An effective method of exome-sequencing has the potential to help researchers identify genetic diseases in record time.
Dr. Nada Jabado at the MUHC and Dr. Jacek Majewski at McGill University led the study
Advertisement
The exome-a small part of the genome- is of crucial interest with regard to research on genetic diseases as it accounts for 85 percent of mutations.
"With this new approach, we no longer need to access patients who share the same altered gene pools to be able to identify the gene responsible for a disease. All we require are two persons affected by the disease not necessarily from the same family," explained Jabado.
![Epigenetics]( "Epigenetics")
In the recent years 'epigenetics' represents inheritable changes in gene expression that do not include DNA alterations.
"Now, within two weeks and with just two patients, we can easily isolate a gene. This compares to a time frame of six or seven months or even years before we saw results with the old process. This is really a positive breakthrough in genetic analysis," he added.
In the study, the researchers focused on isolating the mutation responsible for a rare and deadly genetic syndrome, Fowler's Syndrome, which is involved in the anarchic proliferation of brain vessels that hinder the brain's development.
Their results have revealed - between two patients with no family ties - a rare case of four mutations in the same gene.
This illustrates well the effectiveness of this sequencing technique, the goal of which is to isolate genetic alterations in cases of hereditary diseases among children, regardless of how prevalent they are in society (e.g. mucoviscidosis, sickle-cell anemia).
"These results are very promising. There is now hope that in the near future we can treat a patient presenting a rare, unknown genetic disease in our laboratory, and within a few days be able to sequence his or her DNA to find the mutation that caused the disease," stated Dr. Jacek Majewski.
Owing to this new, rapid and effective genome sequencing process, within one or two years a 'full catalogue' of mutations that are responsible for most hereditary diseases are expected to be revealed, in addition to further advances in many other more complex diseases, such as cancer in children.
"The sequencing of genetic diseases will lead to a change in our medical practices. Each patient could receive a personalized treatment depending on the particular genes involved. By sequencing the patient's genome, we will be better able to target the disease and adapt treatment to achieve the best results, according to tolerance levels for each person," said Jabado.
The results of the study have been published in the journal Human Mutation.
Source: ANI
Epigenetics
In the recent years 'epigenetics' represents inheritable changes in gene expression that do not include DNA alterations.
Advertisement
"Now, within two weeks and with just two patients, we can easily isolate a gene. This compares to a time frame of six or seven months or even years before we saw results with the old process. This is really a positive breakthrough in genetic analysis," he added.
In the study, the researchers focused on isolating the mutation responsible for a rare and deadly genetic syndrome, Fowler's Syndrome, which is involved in the anarchic proliferation of brain vessels that hinder the brain's development.
Their results have revealed - between two patients with no family ties - a rare case of four mutations in the same gene.
This illustrates well the effectiveness of this sequencing technique, the goal of which is to isolate genetic alterations in cases of hereditary diseases among children, regardless of how prevalent they are in society (e.g. mucoviscidosis, sickle-cell anemia).
"These results are very promising. There is now hope that in the near future we can treat a patient presenting a rare, unknown genetic disease in our laboratory, and within a few days be able to sequence his or her DNA to find the mutation that caused the disease," stated Dr. Jacek Majewski.
Owing to this new, rapid and effective genome sequencing process, within one or two years a 'full catalogue' of mutations that are responsible for most hereditary diseases are expected to be revealed, in addition to further advances in many other more complex diseases, such as cancer in children.
"The sequencing of genetic diseases will lead to a change in our medical practices. Each patient could receive a personalized treatment depending on the particular genes involved. By sequencing the patient's genome, we will be better able to target the disease and adapt treatment to achieve the best results, according to tolerance levels for each person," said Jabado.
The results of the study have been published in the journal Human Mutation.
Source: ANI
New Technique Could Give Out Quick and Easy Diagnosis for Mitochondrial Disorders
An innovative clinical diagnostic test for the early identification of a wide range of mitochondrial disorders is described in research published in BioMed Central's open access journal
Advertisement
Advertisement
Recommended Reading
Latest Genetics & Stem Cells News
Can stem cell therapy cure fistula? Yes, treatment with stem cells has had a success rate when used in perianal fistulas due to Crohn's Disease.
In zebrafish models of SURF1 mitochondrial disease, scientists have discovered drugs to prevent neurological decompensation.
New study advances intravitreal gene therapy platform to develop safe and effective therapies for visual loss in Usher Syndrome, rare disorder.
The study experiments shed light on a rare example of how autism-associated mutation could altered nuclear dynamics.
A genotype-first approach to patient care involves selecting patients with specific genomic variants and then studying their traits and symptoms.
